胸外科区域化对肺癌切除术后长期生存的影响
本研究在一体化医疗系统内回顾性比较胸外科区域化前后(2011-2013年 n=782;2015-2017年 n=845)因癌症行主要肺切除的患者,发现区域化后总生存更优,1年死亡率由11.1%降至5.7%,3年死亡率由25.5%降至17.0%,多变量校正后区域化仍与死亡风险降低独立相关(HR 0.57,95%CI 0.42-0.76)。
要点
- 区域化后肺癌切除患者总生存显著改善(log-rank P<.0001)。
- 1年死亡率由11.1%降至5.7%,3年死亡率由25.5%降至17.0%。
- 校正后仅区域化、年龄、癌症分期和Charlson合并症指数为独立预测因素。
核心结论
- 胸外科区域化后肺癌切除术的总死亡率以及1年和3年死亡率均降低。
- 多变量Cox分析校正相关因素后,区域化与死亡率降低的关联仍显著。
- 外科医生手术量、机构手术量、外科医生专业、新辅助治疗和电视辅助胸腔镜手术方式在校正模型中未显著影响死亡率。
研究设计与样本
- 回顾性研究,在一体化医疗系统内比较胸外科区域化前(2011-2013年,n=782)与区域化后(2015-2017年,n=845)因癌症行主要肺切除(肺叶切除、双肺叶切除或全肺切除)的患者。
- 采用Kaplan-Meier分析比较总生存,采用χ2或Fisher精确检验比较1年和3年死亡率,采用多变量Cox回归模型评估区域化对死亡率的影响并校正相关因素。
主要发现
- Kaplan-Meier曲线显示区域化后手术患者的总生存更优(log-rank检验,P<.0001)。
- 区域化后1年死亡率由11.1%降至5.7%(P<.0001),3年死亡率由25.5%降至17.0%(P=.0002)。
- 多变量校正Cox回归显示,仅区域化(HR 0.57;95%CI 0.42-0.76)、年龄(HR 1.03;95%CI 1.02-1.04)、癌症分期(II、III、IV期HR分别为1.72、1.83、2.56)和Charlson合并症指数(1-2分HR 1.80;≥3分HR 2.05)为死亡率的独立预测因素。
临床怎么用
- 胸外科区域化可能与肺癌切除术后长期生存改善相关,支持在医疗系统内推进胸外科手术的区域化集中。
- 评估肺癌切除预后时应考虑区域化、年龄、癌症分期和Charlson合并症指数等独立预测因素。
局限性
- 本研究为回顾性综述,原文摘要未报告其他局限性信息。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Existing evidence demonstrates some benefit of regionalization on early postoperative outcomes following lung cancer resection, but data regarding the persistence of this effect in long-term mortality are lacking. We investigated whether previously reported improvements in short-term outcomes translated to long-term survival benefit. METHODS: We retrospectively reviewed patients undergoing major pulmonary resection (lobectomy, bilobectomy, or pneumonectomy) for cancer within our integrated health care system before (2011-2013; n = 782) and after (2015-2017; n = 845) thoracic surgery regionalization. Overall survival was compared by Kaplan-Meier analysis, and 1- and 3-year mortality was compared by the by χ2 or Fisher exact test. Multivariable Cox regression models evaluated the effect of regionalization on mortality adjusted for relevant factors. RESULTS: Kaplan-Meier curves showed that overall survival was better among patients undergoing surgery postregionalization (log-rank test, P < .0001). Both 1- and 3-year mortality were decreased after regionalization: to 5.7% from 11.1% (P < .0001) for 1 year and to 17.0% from 25.5% (P = .0002) for 3 years. The multivariable adjusted Cox regression analysis revealed that only regionalization (hazard ratio [HR], 0.57; 95% confidence interval [CI], 0.42-0.76), age (HR, 1.03; 95% CI, 1.02-1.04), cancer stage (HR, 1.72, 1.83, and 2.56 for stages II, III, and IV, respectively), and Charlson comorbidity index (HR, 1.80 for 1-2; 2.05 for ≥3) were independent predictors of mortality. CONCLUSIONS: We found that overall mortality as well as 1- and 3-year mortality for lung cancer resection were lower after thoracic surgery regionalization. The association between regionalization and reduced mortality was significant even after adjusting for other related factors in a multivariable Cox analysis. Notably, surgeon volume, facility volume, surgeon specialty, neoadjuvant treatment, and video-assisted thoracoscopic surgery approach did not significantly affect mortality in the adjusted model.
引用
- Ely S, Jiang SF, Dominguez DA, et al. Effect of thoracic surgery regionalization on long-term survival after lung cancer resection. J Thorac Cardiovasc Surg. 2021. PMID: 33934900. doi:10.1016/j.jtcvs.2021.03.050
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。